Position
Chief Growth Officer
Company
GeneDx
Description
Melanie Duquette joining team as Chief Growth Officer to drive commercial excellence, Jennifer Brendel to take new role as Chief of Corporate Affairs amplifying the GeneDx brand and leadership platform STAMFORD, Conn., Sept. 11, 2023 -- GeneDx a leader in delivering improved health outcomes through genomic and clinical insights, today announced the expansion and evolution of its executive leadership team with the appointment of Melanie Duquette as Chief Growth Officer and Jennifer Brendel as Chief of Corporate Affairs. Both executives will report to Katherine Stueland, CEO and President, and will collaborate in continuing to strengthen GeneDx’s market leading position in genomic interpretation and health insights. In her previous position as Chief Commercial Officer for GeneDx, Jen Brendel set the foundation of the commercial footprint and strategy for the Company, which has contributed to the accelerated utilization of exome and genome testing and 40% revenue growth from 2021 to 2022 with continued growth of product mix to 22% in Q2